eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Rosemont Pharmaceuticals Limited
Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, Yorkshire, LS11 9XE
Telephone: +44 (0)113 244 1400
Fax: +44 (0)113 246 0738
WWW: http://www.rosemontpharma.com
Customer Care direct line: +44 (0)800 919 312
Out of Hours Telephone: +44 (0)7836 557 879
Out of Hours contact: pharmacovigilance@rosemontpharma.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 07/05/2010
PIL Nalidixic Acid 300mg/5ml Oral Suspension

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/05/2010 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 01/03/2010 and displayed until 07/05/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 25/11/2009 and displayed until 01/03/2010
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 28/10/2009 and displayed until 25/11/2009
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 26/08/2008 and displayed until 28/10/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 08/05/2008 and displayed until 26/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 15/04/2008 and displayed until 08/05/2008
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 21/09/2005 and displayed until 15/04/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to Further Information section
Updated on 25/09/2002 and displayed until 21/09/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  nalidixic acid